2nd Edition of International Cancer Research Conference
March 19-21, 2026 | Singapore
Prostate Cancer
Prostate cancer remains a significant focus in cancer research due to its prevalence and impact on men's health. Studies delve into various aspects, from understanding its molecular mechanisms to refining diagnostic techniques and treatment options. Researchers explore genetic factors influencing prostate cancer risk and progression, paving the way for personalized medicine approaches. Advanced imaging technologies aid in early detection and monitoring, crucial for improving survival rates. Additionally, immunotherapy and targeted therapies show promise in enhancing treatment efficacy with fewer side effects. Collaborative efforts between scientists, clinicians, and patients drive progress in prostate cancer research, aiming for better outcomes and quality of life for affected individuals. As research continues to evolve, the future holds prospects for more effective prevention, detection, and treatment strategies in combating this prevalent disease.
Rajvir Dahiya
University of California San Francisco, United States
Anyou Wang
DIFIBER LLC, United States
Michael Thompson
University of Toronto, Canada
Can Küçük
Dokuz Eylul University, Turkey
Nadia Leney Olazo Marquez
Benemérita Universidad Autónoma de Puebla, Mexico
Liu Ying
Shanghai University, China
Ratan Kumar Sarkar
Independent Researcher, IndiaSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : Uncovering tumor-suppressive roles of histone modifiers in gastric cancer through spatial transcriptomics and epigenomics
Shilpa S Dhar, UT MD Anderson Cancer Center, United States
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : A case-based approach using IMPeTUs criteria in FDG PET/CT reporting of multiple myeloma
Mudalsha Ravina, All India Institute of Medical Sciences, India
Title : Transforming cancer care: Innovations, integrations, and impact
Shayan Maqsood, Jamia Hamdard University, India
Title : Updates on controversies surrounding the staging and management of newly diagnosed localized prostate cancer using prostate-specific membrane antigen (PSMA) positron emission tomography
Patricia Tai, University of Saskatchewan, Canada